Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Transverse Myelitis Publisher



Maghzi AH1, 2, 3 ; Etemadifar M2, 4 ; Savoj MR2 ; Steven Alexander J5 ; Gonzaleztoledo E6, 7 ; Minagar A7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Neuroimmunology Unit, Centre for Neuroscience and Trauma, Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, United Kingdom
  2. 2. Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Isfahan, Iran
  3. 3. Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, LA, United States
  6. 6. Department of Radiology, Louisiana State University Health Sciences Center, Shreveport, LA, United States
  7. 7. Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, United States

Source: Neuroinflammation Published:2011


Abstract

Acute transverse myelitis (ATM) is an idiopathic inflammatory form of myelopathy that represents only one of the many causes of acute transverse myelopathies. A large and heterogeneous group of pathogenic disorders can cause transverse myelitis, including inflammatory demyelinating disorders like multiple sclerosis (MS), neuromyelitis optica (NMO), and ATM. Transverse myelitis can be classified as either complete or partial. Patients with the complete form of transverse myelitis exhibit more severe symptoms, which indicates involvement of all spinal cord tracts and accompanying loss of corticospinal, sensory, and autonomic functions below the level of the lesion. This form of acute myelopathy is usually observed in the context of trauma or acute necrotizing viral myelitis. The partial form of acute myelitis manifests in several clinical pictures based on the involved tracts. Patients with partial myelitis may present with Brown-Sequard hemicord syndrome, and these patients suffer from ipsilateral corticospinal dysfunction and posterior columnar and contralateral spinothalamic dysfunction. Patients with compressive myelopathies or MS may also present with this form. The first step in treatment is to exclude treatable causes such as compressive lesions, infections, collagen vascular disease, paraneoplastic syndromes, local tumors, and vascular diseases affecting the spinal cord. Based on the underlying pathology, the appropriate treatment should be initiated. © 2011 Elsevier Inc. All rights reserved.